OncoSec Medical Incorporated
ONCS
ONCS was delisted on the 23rd of June, 2023.
22 hedge funds and large institutions have $1.51M invested in OncoSec Medical Incorporated in 2019 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 3 closing their positions.
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
10% more funds holding
Funds holding: 20 → 22 (+2)
4% less capital invested
Capital invested by funds: $1.57M → $1.51M (-$58K)
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$200K |
| 2 |
Renaissance Technologies
New York
|
+$196K |
| 3 |
DADC
D.A. Davidson & Co
Great Falls,
Montana
|
+$51.2K |
| 4 |
LPL Financial
San Diego,
California
|
+$39.5K |
| 5 |
SM
Salzhauer Michael
|
+$30.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$99K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$91.5K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$33K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$1.22K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$422 |
ONCS Hedge Fund Activity: Q3 2019 in Review
22 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in OncoSec Medical Incorporated (ONCS) for Q3 2019, worth a combined $1.51M — down 3.7% from $1.57M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new ONCS positions and 3 closed out — a net gain of 2 holders — while 2 added to existing stakes and 4 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $200K. The largest seller was Worth Venture Partners, exiting entirely with an estimated $99K sold.
- 22 institutional investors held OncoSec Medical Incorporated (ONCS) as of Q3 2019, up from 20 in Q2 2019.
- Funds reported $1.51M of OncoSec Medical Incorporated stock for Q3 2019, down 3.7% quarter-over-quarter.
- 5 funds opened new OncoSec Medical Incorporated positions in Q3 2019 and 3 closed out, a net change of +2 holders.
- The largest OncoSec Medical Incorporated buyer in Q3 2019 was JP Morgan Chase, an estimated $200K added.
- The largest OncoSec Medical Incorporated seller in Q3 2019 was Worth Venture Partners, an estimated $99K sold.
Based on aggregated 13F filings for Q3 2019.